Projecting the Burden of Chronic Kidney Disease in a Developed Country and Its Implications on Public Health

Table 2

Definition of CKD in the CDMS.

Stages of CKD	eGFR	Marker of kidney damage in CDMS
Early; (Stages 12)	≥ 60 ml/min/1.73 m^2	Any 1 of the following: (i) Two UACR lab tests ≥ 2.5 mg/mmol (male), 90 days apart; (ii) Two UACR lab tests ≥ 3.5 mg/mmol (female), 90 days apart; (iii) Two UACR lab tests > 30mg/g, 90 days apart; (iv) Two UPCR lab tests ≥ 20mg/mmol, 90 days apart; (v) Two UPCR lab tests > 0.2mg/mg, 90 days apart; (vi) Two Urine Protein lab tests ≥ 0.2 g/day, 90 days apart
Moderate; (Stage 3A)	45-59 ml/min/1.73 m^2	With or without kidney damage
Moderate; (Stage 3B)	30-44 ml/min/1.73 m^2	With or without kidney damage
Severe; (Stage 4)	15-29 ml/min/1.73 m^2	With or without kidney damage
Severe; (Stage 5)	<15ml/min/1.73 m^2	With or without kidney damage